発作（Seizures）治療のグローバル臨床試験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Seizures 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Seizures to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Seizures to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Seizures 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Seizures Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Seizures 35
Jun 17, 2014: Qudexy XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia 35
Jun 16, 2014: Eisai Announces Phase III Trial with Antiepileptic Drug Perampanel Meets Primary Endpoint as Adjunctive Therapy in Patients with Uncontrolled Primary Generalized Tonic-Clonic Seizures 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
UCB S.A. 36
Clinical Trial Overview of UCB S.A. 36
Pfizer Inc. 42
Clinical Trial Overview of Pfizer Inc. 42
Eisai Co., Ltd. 46
Clinical Trial Overview of Eisai Co., Ltd. 46
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Johnson & Johnson 52
Clinical Trial Overview of Johnson & Johnson 52
GlaxoSmithKline plc 54
Clinical Trial Overview of GlaxoSmithKline plc 54
Bial – Portela & Ca, S.A. 56
Clinical Trial Overview of Bial – Portela & Ca, S.A. 56
SK Holdings Co., Ltd. 57
Clinical Trial Overview of SK Holdings Co., Ltd. 57
H. Lundbeck A/S 58
Clinical Trial Overview of H. Lundbeck A/S 58
Boehringer Ingelheim Auslandsbeteiligungs GmbH 59
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 59
Clinical Trial Overview of Top Institutes / Government 60
National Institute of Neurological Disorders and Stroke 60
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 60
Assistance Publique – Hopitaux de Paris 61
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 61
All India Institute of Medical Sciences 62
Clinical Trial Overview of All India Institute of Medical Sciences 62
Cincinnati Children’s Hospital Medical Center 63
Clinical Trial Overview of Cincinnati Children’s Hospital Medical Center 63
University of California, San Diego 64
Clinical Trial Overview of University of California, San Diego 64
Emory University 65
Clinical Trial Overview of Emory University 65
Yonsei University 66
Clinical Trial Overview of Yonsei University 66
Medical University of South Carolina 67
Clinical Trial Overview of Medical University of South Carolina 67
Eunice Kennedy Shriver National Institute of Child Health and Human Development 68
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 68
Shiraz University of Medical Sciences 69
Clinical Trial Overview of Shiraz University of Medical Sciences 69
Five Key Clinical Profiles 70
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 111
Secondary Research 111
About GlobalData 112
Contact Us 112
Disclaimer 112
Source 112